PLTR Stock Alert: 5 Things to Know About Palantir’s Latest Partnership

InvestorPlace2021-12-21

Despite announcing a new multi-year partnership with Dewpoint Therapeutics, shares of Palantir Technologies(NYSE:PLTR) are down more than 4% on the day. The weakness in PLTR stock can be attributed to...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

brightsun
2021-12-22
brightsun
Plyr long
sk5735
2021-12-22
sk5735
PLTR for long
Dawang
2021-12-21
Dawang
New partnership, new growth, new opportunities. Kachng! 💰💰💰
LEESIMON
2021-12-21
LEESIMON
Great PLTR news⭐️⭐️⭐️
CCKK
2021-12-21
CCKK
Hopefully
- CCKK:
  🙏🏻
koolgal
2021-12-21
koolgal
Palantir's partnership with Dewpoint will be earnings accretive for both companies. Hopefully it will help reverse the downtrend that Palantir is facing too! The new contract with US Army will certainly help too. Go Palantir! 🚀🚀🚀🌙🌙🌙
- koolgal回复traveleat123:
  Thanks
- koolgal回复traveleat123:
  Thanks
- koolgal回复traveleat123:
  My pleasure. Thanks
- traveleat123回复koolgal:
  Thanks for the explanation @koolgal
  
  may those who invested win
- koolgal:
  I agree. There is a lot of interest. I am interested because it is hot.

发表看法

128

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1129749044?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-21 10:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129749044","market":"us","top_or_hot":-1,"title":"PLTR Stock Alert: 5 Things to Know About Palantir’s Latest Partnership","media":"InvestorPlace","content":"<div>\n<p>Despite announcing a new multi-year partnership with Dewpoint Therapeutics, shares of Palantir Technologies(NYSE:PLTR) are down more than 4% on the day. The weakness in PLTR stock can be attributed to...</p>\n\n<a href=\"https://investorplace.com/2021/12/pltr-stock-alert-5-things-to-know-about-palantirs-latest-partnership/\">网页链接</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PLTR Stock Alert: 5 Things to Know About Palantir’s Latest Partnership</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPLTR Stock Alert: 5 Things to Know About Palantir’s Latest Partnership\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 10:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/pltr-stock-alert-5-things-to-know-about-palantirs-latest-partnership/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Despite announcing a new multi-year partnership with Dewpoint Therapeutics, shares of Palantir Technologies(NYSE:PLTR) are down more than 4% on the day. The weakness in PLTR stock can be attributed to...</p>\n\n<a href=\"https://investorplace.com/2021/12/pltr-stock-alert-5-things-to-know-about-palantirs-latest-partnership/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PLTR","symbol_name":"Palantir Technologies Inc.","start_time":0,"source_url":"https://investorplace.com/2021/12/pltr-stock-alert-5-things-to-know-about-palantirs-latest-partnership/","article_id":"1129749044","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129749044","pubTimestamp":1640052616,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"Despite announcing a new multi-year partnership with Dewpoint Therapeutics, shares of Palantir Techn","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"translate_title":"PLTR股票警报：关于Palantir最新合作伙伴关系的5件事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PLTR":0.9},"content_text":"Despite announcing a new multi-year partnership with Dewpoint Therapeutics, shares of Palantir Technologies(NYSE:PLTR) are down more than 4% on the day. The weakness in PLTR stock can be attributed to general market weakness, as the S&P 500 and Nasdaq are both down today. However, let’s dive into the details on the new partnership that has shareholders of PLTR stock excited.\nThe partnership will see Dewpoint utilize Palantir’s Foundry platform to further research and understand condensates biology. The Foundry platform will help researchers analyze lab data and other data sources. Researchers at Dewpoint will also use Foundry to store their centralized knowledge repository. Additionally, they will use it to contextualize test results and prioritize the best possible outcome.\nLalarukh Haris Shaikh, Palantir’s head of biotech, praised the partnership. She commented:\n\n “We think Dewpoint is changing the way the world approaches drug design by exploring new frontiers of disease biology, requiring a game changing solution that goes beyond just cloud and infrastructure to drive their R&D and scale with their vision as they grow. We are proud to partner with Dewpoint and share their passion of working on one of the most exciting translational medicine approaches of our time.”\n\nPLTR Stock: What to Know About the Dewpoint Partnership\n\nDewpoint is a leading research company that seeks to understand the nature of condensates in order to develop drugs. Condensates are involved in many serious diseases, such as cancer, metabolic disease and other rare genetic disorders.\nThe Foundry platform is designed to integrate siloed information sources that will lead to data-driven analysis and conclusions. Foundry will be able to “work seamlessly” with the existing Dewpoint systems.\nFor example, the expansion of Dewpoint’s data foundation to include “advanced genetic analysis for disease association and correlation with condensate content” will help the company discover potential medical breakthroughs.\nDewpoint CEO Ameet Nathwani is looking forward to the prospects that Foundry can bring to the company. He stated that, “Key to our approach has been creating a seamless connection between our wet-lab and dry-lab capabilities, with machine learning and AI at the center. Foundry has provided us with a solid foundation for us to fully connect and operationalize our entire lab to enterprise and enable the discovery and development of new drugs.”\nThis partnership comes after Palantir announced that they had won a second option year with the U.S. Army. Indeed, that deal is worth $116.3 million.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[{"id":691367977,"gmtCreate":1640138810865,"gmtModify":1640138811044,"author":{"id":"3570689780555896","authorId":"3570689780555896","name":"brightsun","avatar":"https://static.tigerbbs.com/50f01966a534f410b4455882da98d0f9","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Plyr long&nbsp;","listText":"Plyr long&nbsp;","text":"Plyr long","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691367977","repostId":1129749044,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":691397045,"gmtCreate":1640134363505,"gmtModify":1640134364966,"author":{"id":"3581741175905126","authorId":"3581741175905126","name":"sk5735","avatar":"https://static.tigerbbs.com/119fc82bddd3291f8c7e303167676732","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"PLTR for long","listText":"PLTR for long","text":"PLTR for long","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691397045","repostId":1129749044,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":693763461,"gmtCreate":1640081786371,"gmtModify":1640081787683,"author":{"id":"3579482809178950","authorId":"3579482809178950","name":"Dawang","avatar":"https://static.tigerbbs.com/d0f01f2346125f600328ffd48beb3a4c","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"New partnership, new growth, new opportunities. Kachng! 💰💰💰","listText":"New partnership, new growth, new opportunities. Kachng! 💰💰💰","text":"New partnership, new growth, new opportunities. Kachng! 💰💰💰","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693763461","repostId":1129749044,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":693461333,"gmtCreate":1640064365061,"gmtModify":1640064365849,"author":{"id":"3579044609497336","authorId":"3579044609497336","name":"LEESIMON","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":9,"crmLevelSwitch":0},"htmlText":"Great PLTR news⭐️⭐️⭐️","listText":"Great PLTR news⭐️⭐️⭐️","text":"Great PLTR news⭐️⭐️⭐️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693461333","repostId":1129749044,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":693414922,"gmtCreate":1640061019789,"gmtModify":1640061298477,"author":{"id":"3569655834816623","authorId":"3569655834816623","name":"CCKK","avatar":"https://static.tigerbbs.com/c6aea8804777ae257ed50c99419ad048","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Hopefully&nbsp;","listText":"Hopefully&nbsp;","text":"Hopefully","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693414922","repostId":1129749044,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7063662,"gmtCreate":1640061034768,"gmtModify":1640061034856,"authorId":3569655834816623,"author":{"id":3569655834816623,"authorId":3569655834816623,"name":"CCKK","avatar":"https://static.tigerbbs.com/c6aea8804777ae257ed50c99419ad048","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":693414922,"type":1,"supId":0,"prevId":0,"content":"🙏🏻","text":"🙏🏻","html":"🙏🏻"}],"langContent":"CN"},{"id":693410289,"gmtCreate":1640059761132,"gmtModify":1640123989387,"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"Palantir's partnership with Dewpoint will be earnings accretive for both companies.&nbsp; Hopefully it will help reverse the downtrend that Palantir is facing too!&nbsp; The new contract with US Army will certainly help too.&nbsp; Go Palantir! 🚀🚀🚀🌙🌙🌙","listText":"Palantir's partnership with Dewpoint will be earnings accretive for both companies.&nbsp; Hopefully it will help reverse the downtrend that Palantir is facing too!&nbsp; The new contract with US Army will certainly help too.&nbsp; Go Palantir! 🚀🚀🚀🌙🌙🌙","text":"Palantir's partnership with Dewpoint will be earnings accretive for both companies. Hopefully it will help reverse the downtrend that Palantir is facing too! The new contract with US Army will certainly help too. Go Palantir! 🚀🚀🚀🌙🌙🌙","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":21,"commentSize":18,"repostSize":0,"link":"https://laohu8.com/post/693410289","repostId":1129749044,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7081584,"gmtCreate":1640213642098,"gmtModify":1640213642098,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":4098682592538030,"repliedAuthor":{"id":4098682592538030,"authorId":4098682592538030,"name":"traveleat123","avatar":"https://static.tigerbbs.com/9b256e8e80bca8c1b6944e22d375ee0b","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":693410289,"type":1,"supId":7064665,"prevId":7078787,"content":"Thanks","text":"Thanks","html":"Thanks"},{"id":7081580,"gmtCreate":1640213636269,"gmtModify":1640213636269,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":4098682592538030,"repliedAuthor":{"id":4098682592538030,"authorId":4098682592538030,"name":"traveleat123","avatar":"https://static.tigerbbs.com/9b256e8e80bca8c1b6944e22d375ee0b","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":693410289,"type":1,"supId":7064665,"prevId":7078787,"content":"Thanks","text":"Thanks","html":"Thanks"},{"id":7081576,"gmtCreate":1640213615374,"gmtModify":1640213615374,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":4098682592538030,"repliedAuthor":{"id":4098682592538030,"authorId":4098682592538030,"name":"traveleat123","avatar":"https://static.tigerbbs.com/9b256e8e80bca8c1b6944e22d375ee0b","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":693410289,"type":1,"supId":7064665,"prevId":7078787,"content":"My pleasure. <u>Thanks</u>","text":"My pleasure. <u>Thanks</u>","html":"My pleasure. <u>Thanks</u>"},{"id":7078787,"gmtCreate":1640186296375,"gmtModify":1640186296409,"authorId":4098682592538030,"author":{"id":4098682592538030,"authorId":4098682592538030,"name":"traveleat123","avatar":"https://static.tigerbbs.com/9b256e8e80bca8c1b6944e22d375ee0b","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3559581955535845,"repliedAuthor":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":693410289,"type":1,"supId":7064665,"prevId":7064766,"content":"Thanks for the explanation <a href=\"https://laohu8.com/U/3559581955535845\"> @</a><a href=\"https://laohu8.com/U/3559581955535845\">koolgal</a><a href=\"https://laohu8.com/U/3559581955535845\"> </a> <p></p>\n<p>may those who invested win</p>","text":"Thanks for the explanation <a href=\"https://laohu8.com/U/3559581955535845\"> @</a><a href=\"https://laohu8.com/U/3559581955535845\">koolgal</a><a href=\"https://laohu8.com/U/3559581955535845\"> </a> <p></p>\n<p>may those who invested win</p>","html":"Thanks for the explanation <a href=\"https://laohu8.com/U/3559581955535845\"> @</a><a href=\"https://laohu8.com/U/3559581955535845\">koolgal</a><a href=\"https://laohu8.com/U/3559581955535845\"> </a> <p></p>\n<p>may those who invested win</p>"},{"id":7069920,"gmtCreate":1640125919618,"gmtModify":1640125919618,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":693410289,"type":1,"supId":7069812,"prevId":0,"content":"I agree.&nbsp; There is a lot of interest. I am interested because it is hot.","text":"I agree.&nbsp; There is a lot of interest. I am interested because it is hot.","html":"I agree.&nbsp; There is a lot of interest. I am interested because it is hot."}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":128,"commentSize":0,"repostSize":0,"favoriteSize":3,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1129749044"}